Anti-Koronavirus-Antikörper

Details

Veröffentlichungs-Nr.

EP4768502

Anmeldetag

27. Dezember 2024

Veröffentlichung

1. Juli 2026

Rechtsraum

EP

IPC

C07K16/10

Abstract

The present invention relates to an anti-coronavirus antibody and its use thereof, particularly for the prevention or treatment of an infection caused by a coronavirus, especially by porcine epidemic diarrhea virus (PEDV). The anti-coronavirus antibody of the present invention comprises or consists of a first heavy chain variable domain comprising a CDR1 sequence comprising or consisting of FVAMA (SEQ ID NO: 1), a CDR2 sequence comprising or consisting of RISSTGTVTNYADSVKG (SEQ ID NO: 2) or a sequence having at least 90% identity with SEQ ID NO: 2, a CDR3 sequence comprising or consisting of VPGNLLP (SEQ ID NO: 3) or a sequence having at least 90% identity with SEQ ID NO: 3.

Anmelder

Firma

Ceva Santé Animale

Land

🇫🇷 Frankreich

Fachgebiete